Safety Study of Melatonin in Stroke Patients

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to evaluate the effect of Melatonin (in a dosage of 14mg daily) for a better clinical outcome in the period three days post stroke.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Wolfson Medical Center
• Treatments: Melatonin

Criteria

Inclusion Criteria:

• within 72hours of ischemic stroke

• age 18-80

• both gender

• ability to sign consent form

Exclusion Criteria:

• intra-cerebral bleeding

• tumour of brain

• multiple sclerosis

• s/p craniotomy

• known allergy to melatonin